14 February 2019 08:30 CET

Karo Intressenter AB äger cirka 66,5 procent av de utestående aktierna i Karo Pharma Aktiebolag efter utgången av den slutliga acceptfristen

#EQT VIII #Karo Pharma

För mer information, klicka här.

Latest news

18 September 2024
EQT to sell Open Systems, a Swiss leader in network and cyber security solutions, to Swiss Post
18 September 2024
Invitation to EQT’s first US capital markets event in New York on October 22, 2024
11 September 2024
EQT Life Sciences leads EUR 93 million oversubscribed Series A round in Pantera, which aims to accelerate global actinium-225 production
10 September 2024
EQT deltar i Sveriges näringslivsdelegation till klimattoppmötet COP
09 September 2024
EQT to acquire GeBBS Healthcare Solutions, a leading healthcare technology solutions provider